Skip to main content
. 2017 Jan 12;7:692. doi: 10.3389/fphys.2016.00692

Figure 3.

Figure 3

Effects of EMV and RNase-EMV on migration and expression of Mek1/2 and p-Erk1/2/Erk1/2 in HBVSMC. (A) Migration of HBVSMC treated with EMV, RNase-EMV or EMV+Mek1/2 inhibitor (PD0325901). (B) Expression of Mek1/2 and p-Erk1/2/Erk1/2. **p < 0.01 vs. vehicle; +p < 0.05, ++p < 0.01 vs. EMV. Scale bar: 400 μm.